Krop Julie 4
4 · DiaMedica Therapeutics Inc. · Filed Nov 3, 2025
Insider Transaction Report
Form 4
Krop Julie
Chief Marketing Officer
Transactions
- Award
Stock Option (right to buy)
2025-08-11+450,000→ 450,000 totalExercise: $4.58Exp: 2035-08-10→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.